Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan.
J Pharmacol Sci. 2010;112(4):459-62. doi: 10.1254/jphs.09343sc. Epub 2010 Mar 20.
Based on radioligand binding and signal transduction assays in our previous study, we have determined the binding pattern and functional efficacy of the constitutively active mutant N111G of angiotensin II type 1 (AT(1)) receptor. We have also shown that the N111G mutant induces homologous internalization through mediation of the AT(1)-receptor antagonist valsartan. In this study we demonstrated that other AT(1)-receptor antagonists, candesartan, losartan, and telmi-sartan, also stimulate internalization of N111G mutant receptor to the same extent. We further showed that the internalization pattern is also similar for all the AT(1)-receptor antagonists.
基于我们之前的研究中的放射性配体结合和信号转导分析,我们已经确定了血管紧张素 II 型 1 (AT(1))受体的组成性激活突变体 N111G 的结合模式和功能效果。我们还表明,N111G 突变体通过 AT(1)-受体拮抗剂缬沙坦的介导诱导同源内化。在这项研究中,我们证明了其他 AT(1)-受体拮抗剂坎地沙坦、氯沙坦和替米沙坦也同样刺激 N111G 突变体受体的内化。我们进一步表明,所有 AT(1)-受体拮抗剂的内化模式也是相似的。